Cerebrospinal Fluid,Concentrations of Hypoxanthine, Xanthine, Uridine and Inosine: High Concentrations of the ATP Metabolite, Hypoxanthine, After Hypoxia

Total Page:16

File Type:pdf, Size:1020Kb

Cerebrospinal Fluid,Concentrations of Hypoxanthine, Xanthine, Uridine and Inosine: High Concentrations of the ATP Metabolite, Hypoxanthine, After Hypoxia J Clin Pathol: first published as 10.1136/jcp.36.1.1 on 1 January 1983. Downloaded from J Clin Pathol 1983;36: 1-8 Cerebrospinal fluid,concentrations of hypoxanthine, xanthine, uridine and inosine: high concentrations of the ATP metabolite, hypoxanthine, after hypoxia RA HARKNESS, RJ LUND* From the Division ofPerinatal Medicine, MRC Clinical Research Centre, and * Department of Paediatrics Northwick Park Hospital, Watford Road, Harrow SUMMARY CSF obtained for clinical purposes from newborn, children and adults has been analysed by high pressure liquid chromatography for hypoxanthine, xanthine, inosine, uridine and urate. Large rises in hypoxanthine and to a lesser extent xanthine occur for about 24 h after hypoxia. High concentrations were associated with later evidence of brain damage or subsequent death. Changes in CSF could be independent of those in plasma. Small or negligible rises were associated with localised and generalised infections including bacterial meningitis, fits, or both. Marked and rapid rises were found after death. These estimations may "predict" the extent of brain damage or brain death. copyright. Damage in many diseases is due to hypoxia. rises could be separated from the slight or negligible Intrapartum hypoxia is recognised as a major cause of changes associated with infection or fits. Brain morbidity and mortality,' 2 yet objective methods for damage or brain death proven by clinical, confirming the diagnosis lack specificity and electrophysiological and ultrasonic methods was comparative measurements are not available.3" The associated with high concentrations. CNS is the most vulnerable system to damage by http://jcp.bmj.com/ hypoxia.5 The central processes in metabolic damage Methods due to hypoxia involve ATP,6 the universal energy currency of cells. A reduction in intracellular ATP CLINICAL can be a measure of the metabolic damage due to Northwick Park is a large general hospital with a hypoxia. Means of estimating ATP breakdown by perinatal department delivering about 3400 infants non-invasive methods are needed in clinical practice per year. The CSF samples analysed were all aliquots are not available. Since clinical indications because serial tissue samples of samples taken for conventional on September 23, 2021 by guest. Protected some of the uncharged products of ATP breakdown, from 1978-1982. In the last two years of the study hypoxanthine, xanthine, and inosine, can escape these aliquots were immediately centrifuged to from cells, concentrations of these oxypurines in remove blood cells and then stored at -200C. This extracelluar fluids like CSF can reflect ATP was advisable because blood staining of samples was breakdown. The compounds hypoxanthine, frequent in newborn CSF in contrast to that from xanthine, and inosine can now be estimated older children and adults. Contamination of over specifically by methods of sufficient sensitivity.' Since about 109 erythrocytes per litre or fluid which was metabolic events in brain will be reflected in its obviously blood stained, resulted in high oxypurine extracellular fluid,8 we have used CSF samples to concentrations and such specimens were not analysed study ATP breakdown in the CNS after hypoxia. or the results were discarded. Clinical records were Results obtained from 1978 to 1982 show raised surveyed to determine the final diagnoses, the timing concentrations of hypoxanthine and xanthine in CSF of clinical abnormalities such as an asphyxial episode, at least 24 h after serious hypoxia in newborn. These and the time of the CSF sample. The clinical criteria *Present address: Dr RJ Lund, 21 Norfolk Street, Harfield Village, for intrapartum asphyxia and some aspects of Charemont 7700, South Africa. the neurological assessment have already been Accepted for publication 16 July 1982 described.2 Neurological status at the time of the CSF 1 J Clin Pathol: first published as 10.1136/jcp.36.1.1 on 1 January 1983. Downloaded from 2 Harkness, Lund sample was specifically noted by JL in 1981. We are 9- indebted to Dr M O'Connor for post-mortem samples of vitreous humour and CSF. For a set of results to be accepted for a normal 8- range no abnormality apart from mild fever or poor feeding had to exist at the time of the sample and subsequent investigation and progress had to be 7-~ I essentially negative. In newborn, the majority ofsuch 0 specimens were taken during a search for evidence of infection. The adult normal range was determined 6- S from a series of CSF samples from patients without marked evidence of metabolic or other disease, 0 stored at -20°C by the Clinical Chemistry 5- Department at Northwick Park Hospital. However, S R-E both sets of "normal" ranges are probably falsely high 0 because some abnormality existed to prompt' the 4- . : *- - taking of the CSF sample. : * BIOCHEMICAL 3- Trichloracetic acid extracts of CSF were analysed by * 0 high pressure liquid chromatography by the methods _ * 0 | of Simmonds and Harkness.7 The results of 2- . bacteriological examinations, cell counts, protein and glucose concentrations by conventional methods . 1- -. were obtained from the case notes. C- Nucleosides, inosine and adenosine, were specifically measured using boronate affinity column copyright. chromatography followed by high performance liquid 0 - i . .~~~~~ chromatography (HPLC) using a gradient of c,2*~~~Hi's scAeeo methanol in phosphate buffer on a C18 Hypersil column. A similar method has been used to measure adenosine and inosine in plasma.9 The nucleoside, Fig. I Normal concentrations in CSFfrom newborn of uridine, the central compound in pyrimidine http://jcp.bmj.com/ metabolism, was measured by the simple and by the hypoxanthine, xanthine, uridine and inosine. The longer a measure of the bars indicate arithmetic means with shorter bars to indicate selective method and this provided +2 SD limits exceptforinosine in which only an upper limit is overall recovery of nucleosides which was used to shown. correct the final analytical results. Geometric mean and range of +2 SD of the Results logarithmically transformed data are therefore shown in Fig. 2. The mean and ranges (,umol/l) were NORMAL INFANTS AND ADULTS hypoxanthine 1-8 (0 S6-5 1), xanthine 1 7 (0 6-4 7), on September 23, 2021 by guest. Protected In 18 "normal" CSF samples from 16 newborn infants uridine 1 6 (0 3 8- 2), and inosine 0 2 (0(1-0). the concentrations of hypoxanthine, xanthine, uridine, and inosine are shown in Fig. 1; the dis- CONCENTRATIONS IN PATHOLOGICAL tribution of values are symmetrical about a mean. An CONDITIONS: HYPOXIA arithmetic mean and range of ±2 SD were therefore In cases of hypoxia CSF concentrations of used. Values (p.mol/l) were for hypoxanthine 3-6 hypoxanthine and xanthine were raised most with (1 8-5-5), xanthine 5 0 (0-9-9 1), uridine 3-3 (0 6-- lesser rises in uridine and inosine. Results for uridine 6 3) inosine 0 7 (0-2 0). Urate, the catabolic product and inosine are not therefore shown with the pattern of hypoxanthine and xanthine, was also estimated in of results in Fig. 3 but are given in Table 1. The upper nine samples which had a mean (+SD) concentration limits of the normal ranges for hypoxanthine and of 30 (+25) ,umol/l. xanthine are shown as a line in Fig. 3. In the first two In a "normal control" series of 29 adults the days after an episode of hypoxia there was a marked concentrations in CSF of hypoxanthine, xanthine, rise in the concentration of hypoxanthine. We have uridine, inosine are shown in Fig. 2. The results little evidence after this but the trend in the data showed an approximately log-normal distribution. suggests no abnormalities are to be expected on day 3 J Clin Pathol: first published as 10.1136/jcp.36.1.1 on 1 January 1983. Downloaded from Raised CSF oxypurines after hypoxia 3 9.0 1000_ Hypoxonthine in CSF Xanthine in CSF 0 500 - 50- 400- 0 300- 40- 200 - 30- a * 100 - 20 *. X X 50 - a - 40- 30- 10 ? -a a 0 E I 20- a * a 0~~~~~ 0 09 0* . 10 0-5- o 04- . ui8~~ o o o 5 . 4- 0 3- 0 02 2- i- copyright. 012 34 5 6 0 1 2 3 4 5 6 0.1 Days after hypoxia _I I * Fig. 3 Concentrations ofhypoxanthine and xanthine in ,,,o.-Ir &-Fs ;5iv s#? CSFafter hypoxia. Symbols show subsequent major clinical findings: * = died, * = brain damaged, 0 = normal, O = congenital hypothyroidism, A = chloramphenical toxicity. The are http://jcp.bmj.com/ Fig. 2 Normal concentrations in CSFfrom adults of horizontal lines the +2 SD limit ofconcentration. hypoxanthine, xanthine, uridine and inosine. The longer bars indicate geometric means with shorter bars to indicate the predetermined criteria. Two of three of our ±2 SD oflogarithmetically transformed data exceptfor survivors with cerebral damage and high hypo- inosine in which only an upper limit is shown. xanthine concentrations were observed to be markedly cyanosed and apnoeic in postnatal after an episode. The three children who survived episodes, one had subsequent renal tubular necrosis. after showing high concentrations of hypoxanthine The third had sustained low Apgar scores, one at 1 on September 23, 2021 by guest. Protected and xanthine have cerebral damage as shown in one min, four at 5 min and subsequent fits. One infant was by electrophysiological evidence of cerebral cortical shown to have brain death by conventional criteria. blindness and in another by ultrasonographic evid- This infant had a cardiac arrest at the age of 12 min; ence of severe cerebral atrophy. The third is an the heart then continued after a later respiratory athetoid spastic. Five infants died with clinical arrest sustaining normal plasma concentrations of evidence of asphyxia and had high concentrations of ATP metabolites, hypoxanthine 1-5, xanthine 1-2, hypoxanthine in their CSF.
Recommended publications
  • Human Hypoxanthine (Guanine) Phosphoribosyltransferase: An
    Proc. NatL Acad. Sci. USA Vol. 80, pp. 870-873, Febriary 1983 Medical Sciences Human hypoxanthine (guanine) phosphoribosyltransferase: An amino acid substitution in a mutant form of the enzyme isolated from a patient with gout (reverse-phase HPLC/peptide mapping/mutant enzyme) JAMES M. WILSON*t, GEORGE E. TARRt, AND WILLIAM N. KELLEY*t Departments of *Internal Medicine and tBiological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109 Communicated by James B. Wyngaarden, November 3, 1982 ABSTRACT We have investigated the molecular basis for a tration ofenzyme protein. in both erythrocytes (3) and lympho- deficiency ofthe enzyme hypoxanthine (guanine) phosphoribosyl- blasts (4); (ii) a normal Vm., a normal Km for 5-phosphoribosyl- transferase (HPRT; IMP:pyrophosphate-phosphoribosyltransfer- 1-pyrophosphate, and a 5-fold increased Km for hypoxanthine ase, EC 2.4.2.8) in a patient with a severe form of gout. We re-. (unpublished data); (iii) a normal isoelectric point (3, 4) and ported in previous studies the isolation of a unique structural migration during nondenaturing polyacrylamide gel electro- variant of HPRT from this patient's erythrocytes and cultured phoresis (4); and (iv) -an apparently smaller subunit molecular lymphoblasts. This enzyme variant, which is called HPRTOnd0., weight as evidenced by an increased mobility during Na- is characterized by a decreased concentration of HPRT protein DodSO4/polyacrylamide gel electrophoresis (3, 4). in erythrocytes and lymphoblasts, a normal Vm.., a 5-fold in- Our study ofthe tryptic peptides and amino acid composition creased Km for hypoxanthine, a normal isoelectric point, and an of apparently smaller subunit molecular weight. Comparative pep- HPRTLondon revealed a single amino acid substitution (Ser tide mapping-experiments revealed a single abnormal tryptic pep- Leu) at position 109.
    [Show full text]
  • Studies on the Mechanism of Action of 6-Mercaptopurine in Sensitive and Resistant L1210 Leukemia in Vitro*
    Studies on the Mechanism of Action of 6-Mercaptopurine in Sensitive and Resistant L1210 Leukemia in Vitro* JACKD. DAVIDSON (Clinical Pharmacology and Experimental Tlierapeutics Service, National Cancer Institute, Betliesda, Md.) SUMMARY A study was made of the effects of 6-mercaptopurine (6-MP) upon nucleic acid metabolism in L1210 leukemia cells in vitro. Pharmacological concentrations of 6-MP inhibited the incorporation of both hypoxanthine and glycine into adenine nucleo- tides. Higher concentrations of 6-MP inhibited the incorporation of hypoxanthine into both adenine and guanine nucleotides. In a subline of L1210 which is resistant to 6-MP there was much less utilization of hypoxanthine than in the sensitive line, and incorporation into both adenine and guanine moieties was strongly inhibited by 6-MP. On the contrary, utilization of glycine for nucleotide purine synthesis was unaffected by 6-MP. These findings support the hypothesis that in L1210 leukemia 6-MP is metabolized to its ribotide, and this produces a metabolic block in the conversion of inosinic acid to adenylic acid. They further indicate that, in the L1210 cells resistant to 6-MP, there is a very limited capacity to convert 6-MP and hypoxanthine to ribotides. This leads to competition between 6-MP and hypoxanthine and to formation of insufficient 6-MP ribotide to cause the critical block. Although 6-mercaptopurine (6-MP) has been purines isolated from L1210 ascites leukemia cells studied with respect to its antitumor activity since have been studied. The results obtained suggest 1952, there is still relatively little information re that the primary antimetabolic activity of 6-MP garding the mechanism of its action.
    [Show full text]
  • A Previously Undescribed Pathway for Pyrimidine Catabolism
    A previously undescribed pathway for pyrimidine catabolism Kevin D. Loh*†, Prasad Gyaneshwar*‡, Eirene Markenscoff Papadimitriou*§, Rebecca Fong*, Kwang-Seo Kim*, Rebecca Parales¶, Zhongrui Zhouʈ, William Inwood*, and Sydney Kustu*,** *Department of Plant and Microbial Biology, 111 Koshland Hall, University of California, Berkeley, CA 94720-3102; ¶Section of Microbiology, 1 Shields Avenue, University of California, Davis, CA 95616; and ʈCollege of Chemistry, 8 Lewis Hall, University of California, Berkeley, CA 94720-1460 Contributed by Sydney Kustu, January 19, 2006 The b1012 operon of Escherichia coli K-12, which is composed of tive N sources. Here we present evidence that the b1012 operon seven unidentified ORFs, is one of the most highly expressed codes for proteins that constitute a previously undescribed operons under control of nitrogen regulatory protein C. Examina- pathway for pyrimidine degradation and thereby confirm the tion of strains with lesions in this operon on Biolog Phenotype view of Simaga and Kos (8, 9) that E. coli K-12 does not use either MicroArray (PM3) plates and subsequent growth tests indicated of the known pathways. that they failed to use uridine or uracil as the sole nitrogen source and that the parental strain could use them at room temperature Results but not at 37°C. A strain carrying an ntrB(Con) mutation, which Behavior on Biolog Phenotype MicroArray Plates. We tested our elevates transcription of genes under nitrogen regulatory protein parental strain NCM3722 and strains with mini Tn5 insertions in C control, could also grow on thymidine as the sole nitrogen several genes of the b1012 operon on Biolog (Hayward, CA) source, whereas strains with lesions in the b1012 operon could not.
    [Show full text]
  • Central Nervous System Dysfunction and Erythrocyte Guanosine Triphosphate Depletion in Purine Nucleoside Phosphorylase Deficiency
    Arch Dis Child: first published as 10.1136/adc.62.4.385 on 1 April 1987. Downloaded from Archives of Disease in Childhood, 1987, 62, 385-391 Central nervous system dysfunction and erythrocyte guanosine triphosphate depletion in purine nucleoside phosphorylase deficiency H A SIMMONDS, L D FAIRBANKS, G S MORRIS, G MORGAN, A R WATSON, P TIMMS, AND B SINGH Purine Laboratory, Guy's Hospital, London, Department of Immunology, Institute of Child Health, London, Department of Paediatrics, City Hospital, Nottingham, Department of Paediatrics and Chemical Pathology, National Guard King Khalid Hospital, Jeddah, Saudi Arabia SUMMARY Developmental retardation was a prominent clinical feature in six infants from three kindreds deficient in the enzyme purine nucleoside phosphorylase (PNP) and was present before development of T cell immunodeficiency. Guanosine triphosphate (GTP) depletion was noted in the erythrocytes of all surviving homozygotes and was of equivalent magnitude to that found in the Lesch-Nyhan syndrome (complete hypoxanthine-guanine phosphoribosyltransferase (HGPRT) deficiency). The similarity between the neurological complications in both disorders that the two major clinical consequences of complete PNP deficiency have differing indicates copyright. aetiologies: (1) neurological effects resulting from deficiency of the PNP enzyme products, which are the substrates for HGPRT, leading to functional deficiency of this enzyme. (2) immunodeficiency caused by accumulation of the PNP enzyme substrates, one of which, deoxyguanosine, is toxic to T cells. These studies show the need to consider PNP deficiency (suggested by the finding of hypouricaemia) in patients with neurological dysfunction, as well as in T cell immunodeficiency. http://adc.bmj.com/ They suggest an important role for GTP in normal central nervous system function.
    [Show full text]
  • Xanthine/Hypoxanthine Assay Kit
    Product Manual Xanthine/Hypoxanthine Assay Kit Catalog Number MET-5150 100 assays FOR RESEARCH USE ONLY Not for use in diagnostic procedures Introduction Xanthine and hypoxanthine are naturally occurring purine derivatives. Xanthine is created from guanine by guanine deaminase, from hypoxanthine by xanthine oxidoreductase, and from xanthosine by purine nucleoside phosphorylase. Xanthine is used as a building block for human and animal drug medications, and is an ingredient in pesticides. In vitro, xanthine and related derivatives act as competitive nonselective phosphodiesterase inhibitors, raising intracellular cAMP, activating Protein Kinase A (PKA), inhibiting tumor necrosis factor alpha (TNF-α) as well as and leukotriene synthesis. Furthermore, xanthines can reduce levels of inflammation and act as nonselective adenosine receptor antagonists. Hypoxanthine is sometimes found in nucleic acids such as in the anticodon of tRNA in the form of its nucleoside inosine. Hypoxanthine is a necessary part of certain cell, bacteria, and parasitic cultures as a substrate and source of nitrogen. For example, hypoxanthine is often a necessary component in malaria parasite cultures, since Plasmodium falciparum needs hypoxanthine to make nucleic acids as well as to support energy metabolism. Recently NASA studies with meteorites found on Earth supported the idea that hypoxanthine and related organic molecules can be formed extraterrestrially. Hypoxanthine can form as a spontaneous deamination product of adenine. Because of its similar structure to guanine, the resulting hypoxanthine base can lead to an error in DNA transcription/replication, as it base pairs with cytosine. Hypoxanthine is typically removed from DNA by base excision repair and is initiated by N- methylpurine glycosylase (MPG).
    [Show full text]
  • Effect of Uridine on Response of 5-Azacytidine-Resistant Human Leukemic Cells to Inhibitors of De Novo Pyrimidine Synthesis1
    [CANCER RESEARCH 44, 5505-5510, December 1984] Effect of Uridine on Response of 5-Azacytidine-resistant Human Leukemic Cells to Inhibitors of de Novo Pyrimidine Synthesis1 S. Grant,2 K. Bhalla,3 and M. Gleyzer Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032 ABSTRACT activity is the most commonly encountered mode of resistance in animal systems (28). A uridine-cytidine kinase-deficient human promyelocytic leu- We have recently isolated a uridine-cytidine kinase-deficient, kemic subline (HL-60-5-aza-Cyd) has been isolated which is highly 5-aza-Cyd-resistant human promyelocytic leukemic sub- highly resistant to the antileukemic agent 5-azacytidine. Resist line (HL-60-5-aza-Cyd) (8) which is capable of surviving 5-aza- ant cells exposed to 10~5 M 5-azacytidine for 2 hr exhibit a Cyd concentrations (10~4 M) that exceed peak plasma levels in marked reduction in both the total ¡ntracellularaccumulation of humans (27). The purpose of the present studies was to assess 5-azacytidine (11.9 versus 156.0 pmol/106 cells) as well as its the metabolism of 5-aza-Cyd in these resistant cells and to incorporation into RNA (3.1 versus 43.4 pmol//ig o-ribose) com examine their response to a variety of clinically available inhibitors pared to the parent line. These biochemical changes are asso of de novo pyrimidine synthesis. Of the latter agents, PALA, an ciated with nearly a 100-fold decrease in sensitivity to the growth inhibitor of aspártele transcarbamylase (26), and pyrazofurin, an inhibitory effects of 5-azacytidine (concentration of drug associ ated with a 50% reduction in cell growth, 3.5 x 10~5 versus 5.0 inhibitor of orotidylate decarboxylase (5), are of particular inter x 10"7 M).
    [Show full text]
  • Mechanism of Excessive Purine Biosynthesis in Hypoxanthine- Guanine Phosphoribosyltransferase Deficiency
    Mechanism of excessive purine biosynthesis in hypoxanthine- guanine phosphoribosyltransferase deficiency Leif B. Sorensen J Clin Invest. 1970;49(5):968-978. https://doi.org/10.1172/JCI106316. Research Article Certain gouty subjects with excessive de novo purine synthesis are deficient in hypoxanthineguanine phosphoribosyltransferase (HG-PRTase [EC 2.4.2.8]). The mechanism of accelerated uric acid formation in these patients was explored by measuring the incorporation of glycine-14C into various urinary purine bases of normal and enzyme-deficient subjects during treatment with the xanthine oxidase inhibitor, allopurinol. In the presence of normal HG-PRTase activity, allopurinol reduced purine biosynthesis as demonstrated by diminished excretion of total urinary purine or by reduction of glycine-14C incorporation into hypoxanthine, xanthine, and uric acid to less than one-half of control values. A boy with the Lesch-Nyhan syndrome was resistant to this effect of allopurinol while a patient with 12.5% of normal enzyme activity had an equivocal response. Three patients with normal HG-PRTase activity had a mean molar ratio of hypoxanthine to xanthine in the urine of 0.28, whereas two subjects who were deficient in HG-PRTase had reversal of this ratio (1.01 and 1.04). The patterns of 14C-labeling observed in HG-PRTase deficiency reflected the role of hypoxanthine as precursor of xanthine. The data indicate that excessive uric acid in HG-PRTase deficiency is derived from hypoxanthine which is insufficiently reutilized and, as a consequence thereof, catabolized inordinately to uric acid. The data provide evidence for cyclic interconversion of adenine and hypoxanthine derivatives. Cleavage of inosinic acid to hypoxanthine via inosine does […] Find the latest version: https://jci.me/106316/pdf Mechanism of Excessive Purine Biosynthesis in Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency LEIF B.
    [Show full text]
  • Non-Utilization of Radioactive Lodinated Uracil, Uridine, and Orotic Acid by Animal Tissues in Vivo W
    Non-utilization of Radioactive lodinated Uracil, Uridine, and Orotic Acid by Animal Tissues in Vivo W. H. PRUSOFF,WL. HOLMES,tANDA. D. WELCH Department of Pharmacology, School of Medicine, Western Reserve University, Cleveland, Ohio) Adenine (1, 6), guanine (1, 3, 5), cytidine (13), lometric localization of brain tumors. Further desoxycytidine (18), thymidine (18), and orotic more, an I'3-labeled oxazine dye had a significant acid (2), can be utilized by certain mammalian or effect in prolonging the life of mice bearing trans ganisms for the synthesis of nucleic acids ; and the planted tumors (19). If an effective and easily syn rate of incorporation of many of these compounds thesized radioactive iodine-labeled compound into the nucleic acids of rapidly growing tissues, could be found, the possibility might be afforded of such as regenerating liver or neoplastic tissues, is the comparable use of compounds labeled with greater than into those of resting tissues (10, 21). eka-iodine (astatine2@), a potent emitter of alpha Although 8-azaguanine is not a naturally occur particles, although this element is prepared with ring compound, evidence that it can be incorpo difficulty and has the inconveniently short half rated to a small extent into mammalian nucleic life of 7.5 hours (12). acids has been presented (16). This analog of gua Three P3-labeled pyrimidines, iodouridine-5- nine markedly inhibited the growth of Tetrahy I'S', iodouracil-5-I'31, and iodoorotic acid-5-P31, mena geleii, a guanine-requiring protozoan, and of were synthesized, and their incorporation into nor certain experimental tumors. Kidder et al.
    [Show full text]
  • Xj 128 IUMP Glucose Substance Will Be Provisionally Referred to As UDPX (Fig
    426 Studies on Uridine-Diphosphate-Glucose By A. C. PALADINI AND L. F. LELOIR Instituto de Inve8tigacione&s Bioquimicas, Fundacion Campomar, J. Alvarez 1719, Buenos Aires, Argentina (Received 18 September 1951) A previous paper (Caputto, Leloir, Cardini & found that the substance supposed to be uridine-2'- Paladini, 1950) reported the isolation of the co- phosphate was uridine-5'-phosphate. The hydrolysis enzyme of the galactose -1- phosphate --glucose - 1 - product of UDPG has now been compared with a phosphate transformation, and presented a tenta- synthetic specimen of uridine-5'-phosphate. Both tive structure for the substance. This paper deals substances were found to be identical as judged by with: (a) studies by paper chromatography of puri- chromatographic behaviour (Fig. 1) and by the rate fied preparations of uridine-diphosphate-glucose (UDPG); (b) the identification of uridine-5'-phos- 12A UDPG phate as a product of hydrolysis; (c) studies on the ~~~~~~~~~~~~~(a) alkaline degradation of UDPG, and (d) a substance similar to UDPG which will be referred to as UDPX. UMP Adenosine UDPG preparation8 8tudied by chromatography. 0 UjDPX Paper chromatography with appropriate solvents 0 has shown that some of the purest preparations of UDP UDPG which had been obtained previously contain two other compounds, uridinemonophosphate 0 4 (UMP) and a substance which appears to have the same constitution as UDPG except that it contains an unidentified component instead of glucose. This Xj 128 IUMP Glucose substance will be provisionally referred to as UDPX (Fig. la). The three components have been tested for co- enzymic activity in the galactose-1-phosphate-- 0-4 -J UDPX glucose-l-phosphate transformation, and it has been confirmed that UDPG is the active substance.
    [Show full text]
  • Availability and Quality of Published Data on the Purine Content of Foods, ⋆ T Alcoholic Beverages, and Dietary Supplements ⁎ Beiwen Wua, , Janet M
    Journal of Food Composition and Analysis 84 (2019) 103281 Contents lists available at ScienceDirect Journal of Food Composition and Analysis journal homepage: www.elsevier.com/locate/jfca Study Review Availability and quality of published data on the purine content of foods, ⋆ T alcoholic beverages, and dietary supplements ⁎ Beiwen Wua, , Janet M. Roselandb, David B. Haytowitzb,1, Pamela R. Pehrssonb, Abby G. Ershowc a Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA b Methods and Application of Food Composition Laboratory, Agricultural Research Service, US Department of Agriculture, Beltsville, MD 20705, USA c Office of Dietary Supplements, National Institutes of Health, Bethesda, MD 20892, USA ARTICLE INFO ABSTRACT Keywords: Gout, the most common type of inflammatory arthritis and associated with elevated uric acid levels, is aglobal Purine burden. “Western” dietary habits and lifestyle, and the resulting obesity epidemic, are often blamed for the Adenine increased prevalence of gout. Purine intake has shown the biggest dietary impact on uric acid. To manage this Guanine situation, data on the purine content of foods are needed. To assess availability and quality of purine data and Hypoxanthine identify research gaps, we obtained data for four purine bases (adenine, guanine, hypoxanthine, and xanthine) in Xanthine foods, alcoholic beverages, and dietary supplements. Data were predominantly from Japan, and very little from Gout Hyperuricemia the United States. Data quality was examined using a modified version of the USDA Data Quality Evaluation Food analysis System. Purine values in 298 foods/19 food groups, 15 alcoholic beverages, and 13 dietary supplements were Food composition reported. Mean hypoxanthine (mg/100 g) in the soups/sauces group was 112 and mean adenine in poultry Data quality organs was 62.4, which were the highest among all groups.
    [Show full text]
  • Non-Enzymatic Synthesis of the Coenzymes, Uridine Diphosphate
    N O N - E N Z Y M A T I C S Y N T H E S I S OF THE C O E N Z Y M E S , U R I D I N E D I P H O S P H A T E G L U C O S E A N D C Y T I D I N E D I P H O S P H A T E C H O L I N E , A N D O T H E R P H O S P H O R Y L A T E D M E T A B O L I C I N T E R M E D I A T E S A. M A R , J. D W O R K I N , and J. ORO* Department of Biochemical and Biophysical Sciences, University of Houston, Houston, TX 77004, U.S.A. (Received 3 November, 1986) Abstract. The synthesis of uridine diphosphate glucose (UDPG), cytidine diphosphate choline (CDP- choline), glucose-l-phosphate (G1P) and glucose-6-phosphate (G6P) has been accomplished under simulated prebiotic conditions using urea and cyanamide, two condensing agents considered to have been present on the primitive Earth. The synthesis of UDPG was carried out by reacting G1P and UTP at 70 °C for 24 hours in the presence of the condensing agents in an aqueous medium. CDP-choline was obtained under the same conditions by reacting choline phosphate and CTP. G1P and G6P were synthesized from glucose and inorganic phosphate at 70°C for 16 hours.
    [Show full text]
  • Developmental Disorder Associated with Increased Cellular Nucleotidase Activity (Purine-Pyrimidine Metabolism͞uridine͞brain Diseases)
    Proc. Natl. Acad. Sci. USA Vol. 94, pp. 11601–11606, October 1997 Medical Sciences Developmental disorder associated with increased cellular nucleotidase activity (purine-pyrimidine metabolismyuridineybrain diseases) THEODORE PAGE*†,ALICE YU‡,JOHN FONTANESI‡, AND WILLIAM L. NYHAN‡ Departments of *Neurosciences and ‡Pediatrics, University of California at San Diego, La Jolla, CA 92093 Communicated by J. Edwin Seegmiller, University of California at San Diego, La Jolla, CA, August 7, 1997 (received for review June 26, 1997) ABSTRACT Four unrelated patients are described with a represent defects of purine metabolism, although no specific syndrome that included developmental delay, seizures, ataxia, enzyme abnormality has been identified in these cases (6). In recurrent infections, severe language deficit, and an unusual none of these disorders has it been possible to delineate the behavioral phenotype characterized by hyperactivity, short mechanism through which the enzyme deficiency produces the attention span, and poor social interaction. These manifesta- neurological or behavioral abnormalities. Therapeutic strate- tions appeared within the first few years of life. Each patient gies designed to treat the behavioral and neurological abnor- displayed abnormalities on EEG. No unusual metabolites were malities of these disorders by replacing the supposed deficient found in plasma or urine, and metabolic testing was normal metabolites have not been successful in any case. except for persistent hypouricosuria. Investigation of purine This report describes four unrelated patients in whom and pyrimidine metabolism in cultured fibroblasts derived developmental delay, seizures, ataxia, recurrent infections, from these patients showed normal incorporation of purine speech deficit, and an unusual behavioral phenotype were bases into nucleotides but decreased incorporation of uridine.
    [Show full text]